We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Breast Implants Do Not Increase Mortality

By HospiMedica staff writers
Posted on 06 Jan 2005
A study investigating the effects of breast reconstruction with implants after a mastectomy revealed not only that implants do not increase mortality but, on the contrary, they appear to decrease mortality substantially.

The study involved more than 4,000 women under 65 years of age, all diagnosed with early-stage breast cancer. More...
All had been treated with mastectomy and followed over a period of about 12 years after their diagnosis. Analysis revealed that out of the 21% of women who had an implant following mastectomy, there was a 12.4% mortality rate due to breast cancer, compared to a rate of 19.7% in women without an implant. Those women who had the implant were more likely to be younger and of white ethnicity than women with no implant. After adjusting for clinical and socio-demographic factors, the authors concluded that breast cancer mortality in patients with breast implants was about half that of patients without implants.

The study was conducted by researchers at the Northern California Cancer Center (Fremont, CA, USA). The results were reported in Breast Cancer Research, published online by BioMed Central.

"Certainly, further research is needed to explain this survival differential in women with breast implants and those without, by examining potentially explanatory factors such as socioeconomic status, comorbidity, smoking, or other lifestyle factors,” the authors wrote.





Related Links:
Northern Cal. Cancer Ctr.
BioMed Central

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.